LORATADINE TABLET

LORATADINE TABLET was reported 54049 times

LORATADINE TABLET is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT 61 0.1393
1 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 568 0.0835
2 CHRONIC SPONTANEOUS URTICARIA 76 0.0655
3 INAPPROPRIATE PRESCRIBING 34 0.0552
4 PRODUCT PACKAGE ASSOCIATED INJURY 77 0.0345
5 EXTRA DOSE ADMINISTERED 1224 0.0302
6 PATIENT DISSATISFACTION WITH TREATMENT 56 0.0290
7 ALLERGY TO ANIMAL 30 0.0281
8 BUTTERFLY RASH 28 0.0276
9 DRUG EFFECT DELAYED 121 0.0267
10 ESSENTIAL HYPERTENSION 44 0.0240
11 RHINITIS ALLERGIC 96 0.0215
12 MAST CELL ACTIVATION SYNDROME 29 0.0207
13 NEPHROGENIC ANAEMIA 94 0.0203
14 SEASONAL ALLERGY 285 0.0201
15 EXPIRED PRODUCT ADMINISTERED 641 0.0193
16 ACUTE SINUSITIS 33 0.0191
17 PRE-EXISTING CONDITION IMPROVED 111 0.0178
18 NASAL DRYNESS 108 0.0172
19 INFUSION SITE DISCHARGE 30 0.0171
20 CHOLECYSTITIS CHRONIC 113 0.0169
21 UPPER-AIRWAY COUGH SYNDROME 137 0.0166
22 HYPERPARATHYROIDISM SECONDARY 41 0.0163
23 SINUS PAIN 38 0.0163
24 MULTIPLE ALLERGIES 126 0.0161
25 EXPIRED DRUG ADMINISTERED 77 0.0155
26 INCORRECT DOSAGE ADMINISTERED 76 0.0155
27 INFUSION SITE INFECTION 36 0.0155
28 WHITE BLOOD CELLS URINE POSITIVE 29 0.0154
29 PRODUCT PACKAGING DIFFICULT TO OPEN 40 0.0153
30 INFUSION SITE HAEMORRHAGE 50 0.0152
31 EAR CONGESTION 40 0.0147
32 DRUG EFFECT INCOMPLETE 520 0.0143
33 PARANASAL SINUS DISCOMFORT 54 0.0143
34 ANXIETY DISORDER 46 0.0138
35 SNEEZING 307 0.0137
36 OTITIS MEDIA 45 0.0136
37 DEVICE INFUSION ISSUE 33 0.0133
38 CHRONIC SINUSITIS 49 0.0130
39 INFUSION SITE PRURITUS 41 0.0130
40 THERAPEUTIC RESPONSE UNEXPECTED 569 0.0127
41 MONOCYTE COUNT INCREASED 46 0.0127
42 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 90 0.0125
43 INFUSION SITE SWELLING 75 0.0119
44 SINUS HEADACHE 70 0.0118
45 SINUS CONGESTION 157 0.0116
46 LUMBAR SPINAL STENOSIS 33 0.0113
47 SPINAL OSTEOARTHRITIS 99 0.0113
48 SNORING 42 0.0111
49 PARANASAL SINUS HYPERSECRETION 42 0.0110
50 LACTOSE INTOLERANCE 28 0.0109
51 INFUSION SITE ERYTHEMA 92 0.0109
52 NASAL DISORDER 28 0.0105
53 SINUS DISORDER 208 0.0105
54 NASAL CONGESTION 617 0.0105
55 POST-TRAUMATIC STRESS DISORDER 70 0.0104
56 NON-CARDIAC CHEST PAIN 33 0.0104
57 SLEEP APNOEA SYNDROME 198 0.0104
58 INFUSION SITE PAIN 133 0.0103
59 MIGRAINE WITH AURA 28 0.0103
60 ARTHROPOD BITE 75 0.0101
61 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 55 0.0101
62 LACRIMATION INCREASED 304 0.0101
63 NASAL DISCOMFORT 79 0.0100
64 ACCIDENTAL OVERDOSE 364 0.0099
65 INCREASED UPPER AIRWAY SECRETION 51 0.0099
66 THROMBOPHLEBITIS SUPERFICIAL 30 0.0099
67 VITAMIN B12 DEFICIENCY 40 0.0099
68 THERAPEUTIC PRODUCT INEFFECTIVE 38 0.0098
69 RHINORRHOEA 618 0.0096
70 EAR PRURITUS 33 0.0094
71 DERMATITIS CONTACT 106 0.0093
72 POOR QUALITY DRUG ADMINISTERED 60 0.0093
73 REBOUND ACID HYPERSECRETION 28 0.0092
74 DRY THROAT 94 0.0092
75 TEMPERATURE INTOLERANCE 95 0.0092
76 SINUSITIS 937 0.0091
77 HYPERLIPIDAEMIA 109 0.0091
78 VITAMIN D DEFICIENCY 87 0.0089
79 HIATUS HERNIA 114 0.0088
80 THROAT CLEARING 33 0.0088
81 EAR DISCOMFORT 90 0.0088
82 THROAT IRRITATION 390 0.0087
83 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 254 0.0087
84 HEAD DISCOMFORT 153 0.0086
85 HAIR DISORDER 71 0.0086
86 POOR QUALITY SLEEP 185 0.0086
87 DIABETIC NEUROPATHY 42 0.0085
88 RHINOVIRUS INFECTION 33 0.0085
89 INTERVERTEBRAL DISC DEGENERATION 78 0.0084
90 THYROID MASS 32 0.0083
91 TRICUSPID VALVE INCOMPETENCE 66 0.0083
92 CAROTID ARTERY STENOSIS 29 0.0083
93 DRUG EFFECT DECREASED 445 0.0083
94 HANGOVER 29 0.0082
95 SCOLIOSIS 51 0.0082
96 CHOLECYSTITIS ACUTE 46 0.0081
97 PERIORBITAL OEDEMA 42 0.0081
98 MIDDLE INSOMNIA 151 0.0081
99 ATELECTASIS 78 0.0081
100 EAR PAIN 156 0.0080
101 BLOOD PRESSURE SYSTOLIC DECREASED 36 0.0079
102 BRONCHITIS 585 0.0079
103 GASTROOESOPHAGEAL REFLUX DISEASE 627 0.0078
104 BONE LESION 28 0.0078
105 RESPIRATORY TRACT CONGESTION 123 0.0077
106 NASAL POLYPS 38 0.0077
107 SOMNOLENCE 1538 0.0076
108 SPUTUM DISCOLOURED 72 0.0076
109 HAIR TEXTURE ABNORMAL 101 0.0075
110 STREPTOCOCCAL INFECTION 42 0.0075
111 AORTIC VALVE INCOMPETENCE 32 0.0075
112 ROSACEA 35 0.0075
113 CANDIDIASIS 30 0.0075
114 HAIR COLOUR CHANGES 93 0.0075
115 URTICARIA 1244 0.0074
116 MITRAL VALVE INCOMPETENCE 84 0.0074
117 SKIN PLAQUE 62 0.0073
118 DIVERTICULUM INTESTINAL 32 0.0073
119 DIVERTICULUM 52 0.0073
120 HAEMORRHAGIC ANAEMIA 32 0.0073
121 PRODUCT PRESCRIBING ISSUE 158 0.0072
122 END STAGE RENAL DISEASE 132 0.0072
123 FEELING JITTERY 136 0.0071
124 DEMYELINATION 29 0.0071
125 PRODUCT USE ISSUE 1328 0.0071
126 FRUSTRATION TOLERANCE DECREASED 57 0.0070
127 VASCULAR DEVICE INFECTION 32 0.0070
128 ANEURYSM 35 0.0070
129 HAEMOGLOBIN INCREASED 32 0.0070
130 PERIPHERAL VASCULAR DISORDER 36 0.0070
131 EYE SWELLING 258 0.0069
132 PARAESTHESIA ORAL 100 0.0069
133 INITIAL INSOMNIA 71 0.0069
134 GALLBLADDER DISORDER 123 0.0069
135 ONYCHOCLASIS 47 0.0068
136 ASTHMA 768 0.0068
137 SPINAL COLUMN STENOSIS 32 0.0068
138 PHOTOSENSITIVITY REACTION 111 0.0067
139 FACIAL PAIN 60 0.0067
140 EYE PRURITUS 224 0.0067
141 PRODUCT ADMINISTRATION INTERRUPTED 52 0.0066
142 EAR INFECTION 176 0.0066
143 OBSESSIVE-COMPULSIVE DISORDER 53 0.0066
144 UPPER RESPIRATORY TRACT INFECTION 304 0.0066
145 PRODUCT TASTE ABNORMAL 89 0.0066
146 RENAL CYST 52 0.0065
147 PHARYNGEAL SWELLING 64 0.0065
148 TENSION HEADACHE 28 0.0065
149 WEIGHT FLUCTUATION 68 0.0065
150 TENDERNESS 67 0.0064
151 BREAST MASS 43 0.0064
152 IMPAIRED QUALITY OF LIFE 92 0.0064
153 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 351 0.0064
154 LIGAMENT SPRAIN 63 0.0064
155 SKIN WARM 37 0.0064
156 PAIN IN JAW 180 0.0063
157 EXOSTOSIS 58 0.0063
158 FOOD ALLERGY 49 0.0063
159 CARDIOMEGALY 78 0.0063
160 RHINITIS 51 0.0063
161 CHEILITIS 34 0.0063
162 CARPAL TUNNEL SYNDROME 88 0.0063
163 ORAL PAIN 140 0.0062
164 DRUG INEFFECTIVE 8188 0.0062
165 PSYCHOMOTOR HYPERACTIVITY 103 0.0062
166 BONE PAIN 363 0.0062
167 INCREASED TENDENCY TO BRUISE 57 0.0062
168 NOCTURIA 75 0.0062
169 THROAT TIGHTNESS 167 0.0062
170 RESTLESS LEGS SYNDROME 112 0.0062
171 MUSCULOSKELETAL DISCOMFORT 106 0.0062
172 CONCOMITANT DISEASE AGGRAVATED 38 0.0062
173 BLOOD MAGNESIUM DECREASED 53 0.0061
174 SPINAL DISORDER 58 0.0061
175 MADAROSIS 71 0.0061
176 PRODUCT PACKAGING ISSUE 58 0.0061
177 ENERGY INCREASED 36 0.0061
178 CHRONIC KIDNEY DISEASE 462 0.0061
179 SCRATCH 64 0.0061
180 THIRST 108 0.0060
181 LIP SWELLING 201 0.0060
182 MENISCUS INJURY 37 0.0060
183 RENAL FAILURE CHRONIC 46 0.0060
184 VITAMIN D DECREASED 51 0.0060
185 RED BLOOD CELL COUNT DECREASED 170 0.0059
186 THERMAL BURN 42 0.0059
187 MUSCLE STRAIN 51 0.0059
188 CARDIAC MURMUR 51 0.0059
189 BLOOD URIC ACID INCREASED 34 0.0059
190 ARTERIOSCLEROSIS CORONARY ARTERY 39 0.0059
191 BREATH SOUNDS ABNORMAL 29 0.0059
192 ENDOMETRIOSIS 28 0.0059
193 ODYNOPHAGIA 35 0.0059
194 PHLEBITIS 30 0.0059
195 BURSITIS 71 0.0058
196 IRON DEFICIENCY ANAEMIA 54 0.0058
197 SUPRAVENTRICULAR TACHYCARDIA 56 0.0058
198 NERVOUSNESS 305 0.0058
199 PHARYNGOLARYNGEAL PAIN 31 0.0058
200 PRODUCTIVE COUGH 278 0.0058
201 MUSCLE TIGHTNESS 94 0.0058
202 TOOTHACHE 105 0.0058
203 BODY HEIGHT DECREASED 62 0.0058
204 SOMNAMBULISM 38 0.0058
205 IRRITABLE BOWEL SYNDROME 124 0.0058
206 BLOOD POTASSIUM DECREASED 173 0.0057
207 SECRETION DISCHARGE 72 0.0057
208 MAJOR DEPRESSION 42 0.0057
209 HYPERSENSITIVITY 1066 0.0057
210 OROPHARYNGEAL PAIN 531 0.0057
211 CARDIAC FLUTTER 37 0.0057
212 SENSITIVITY TO WEATHER CHANGE 30 0.0057
213 EYE DISCHARGE 59 0.0057
214 WHEEZING 335 0.0056
215 SWELLING FACE 367 0.0056
216 THERAPEUTIC RESPONSE SHORTENED 186 0.0056
217 DRY MOUTH 455 0.0056
218 ROTATOR CUFF SYNDROME 72 0.0056
219 OSTEOPENIA 85 0.0056
220 DRY EYE 278 0.0056
221 EPISTAXIS 416 0.0056
222 SCAR 95 0.0055
223 OROPHARYNGEAL DISCOMFORT 50 0.0055
224 PRODUCT USE COMPLAINT 87 0.0055
225 COUGH 1548 0.0055
226 SWOLLEN TONGUE 172 0.0055
227 SCREAMING 35 0.0055
228 INTERVERTEBRAL DISC PROTRUSION 120 0.0055
229 GASTROENTERITIS VIRAL 99 0.0055
230 PHARYNGITIS 68 0.0055
231 NEUTROPHIL COUNT INCREASED 56 0.0055
232 SENSATION OF FOREIGN BODY 46 0.0055
233 URINE ODOUR ABNORMAL 32 0.0054
234 HYPERKERATOSIS 30 0.0054
235 MICTURITION URGENCY 62 0.0054
236 CHOLELITHIASIS 178 0.0054
237 CONCUSSION 42 0.0054
238 HEART RATE INCREASED 534 0.0054
239 EXERCISE TOLERANCE DECREASED 31 0.0054
240 DYSPNOEA EXERTIONAL 202 0.0054
241 INSURANCE ISSUE 82 0.0054
242 HAEMORRHOIDS 104 0.0053
243 ANOSMIA 77 0.0053
244 TOOTH INFECTION 70 0.0053
245 NERVE COMPRESSION 49 0.0053
246 CHOLECYSTITIS 63 0.0053
247 PALPITATIONS 617 0.0053
248 PHARYNGEAL OEDEMA 81 0.0053
249 RED BLOOD CELL SEDIMENTATION RATE INCREASED 58 0.0052
250 CHEST DISCOMFORT 536 0.0052
251 CRYING 190 0.0052
252 BLOOD PRESSURE INCREASED 797 0.0052
253 PHOTOPHOBIA 98 0.0052
254 OVARIAN CYST 52 0.0052
255 BLOOD UREA INCREASED 87 0.0052
256 ANAPHYLACTIC REACTION 287 0.0052
257 HAEMATOCRIT DECREASED 103 0.0052
258 POSTOPERATIVE WOUND INFECTION 35 0.0052
259 PHARYNGITIS STREPTOCOCCAL 56 0.0052
260 WHITE BLOOD CELL COUNT ABNORMAL 33 0.0052
261 PULMONARY MASS 77 0.0052
262 GASTRITIS 136 0.0052
263 EXTRASYSTOLES 36 0.0052
264 ULCER 82 0.0051
265 BIPOLAR DISORDER 56 0.0051
266 INSOMNIA 1369 0.0051
267 TINNITUS 235 0.0051
268 VENTRICULAR EXTRASYSTOLES 53 0.0051
269 FIBROMYALGIA 124 0.0051
270 OSTEOARTHRITIS 216 0.0051
271 MULTIPLE INJURIES 32 0.0051
272 DENTAL CARIES 56 0.0051
273 LYMPHOEDEMA 35 0.0051
274 HYPERSOMNIA 145 0.0051
275 VISUAL DISTURBANCE 29 0.0050
276 CORONARY ARTERY DISEASE 153 0.0050
277 DECUBITUS ULCER 41 0.0050
278 BLOOD PRESSURE SYSTOLIC INCREASED 98 0.0050
279 SYMPTOM RECURRENCE 30 0.0050
280 ORAL CANDIDIASIS 66 0.0050
281 BLOOD URINE PRESENT 95 0.0050
282 PNEUMONIA ASPIRATION 125 0.0050
283 PRODUCT USE IN UNAPPROVED INDICATION 1236 0.0050
284 LUNG INFILTRATION 44 0.0050
285 DEEP VEIN THROMBOSIS 321 0.0049
286 NECK PAIN 276 0.0049
287 UTERINE LEIOMYOMA 36 0.0049
288 DECREASED INTEREST 29 0.0049
289 LOW DENSITY LIPOPROTEIN INCREASED 38 0.0049
290 RASH PRURITIC 266 0.0049
291 GLUCOSE TOLERANCE IMPAIRED 29 0.0049
292 NEURALGIA 119 0.0049
293 LACERATION 46 0.0049
294 BLOOD IRON DECREASED 58 0.0049
295 PLEURISY 29 0.0049
296 VITREOUS FLOATERS 48 0.0049
297 FLUSHING 496 0.0049
298 BLOOD ALKALINE PHOSPHATASE INCREASED 121 0.0049
299 LOWER GASTROINTESTINAL HAEMORRHAGE 36 0.0049
300 VIRAL INFECTION 162 0.0049
301 HYPERCHOLESTEROLAEMIA 47 0.0049
302 RASH PAPULAR 109 0.0049
303 EMPHYSEMA 49 0.0049
304 PULMONARY CONGESTION 64 0.0048
305 MOUTH SWELLING 28 0.0048
306 MIGRAINE 463 0.0048
307 BRAIN FOG 76 0.0048
308 MUSCULOSKELETAL CHEST PAIN 75 0.0048
309 SOCIAL AVOIDANT BEHAVIOUR 28 0.0048
310 TONGUE DISORDER 35 0.0048
311 BLADDER DISORDER 48 0.0048
312 ECONOMIC PROBLEM 73 0.0048
313 FEELING ABNORMAL 1154 0.0048
314 DYSGEUSIA 356 0.0048
315 ANKLE FRACTURE 74 0.0048
316 DYSPHONIA 279 0.0048
317 INGUINAL HERNIA 29 0.0048
318 FEELING HOT 291 0.0047
319 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 39 0.0047
320 APHONIA 66 0.0047
321 DIVERTICULITIS 131 0.0047
322 SKIN INFECTION 53 0.0047
323 SPINAL COMPRESSION FRACTURE 39 0.0047
324 FEELING DRUNK 35 0.0047
325 OBESITY 75 0.0047
326 PULMONARY HYPERTENSION 98 0.0047
327 QUALITY OF LIFE DECREASED 63 0.0047
328 CONJUNCTIVITIS 87 0.0047
329 DYSPEPSIA 461 0.0047
330 ORAL DISCOMFORT 65 0.0047
331 CYST 58 0.0047
332 PRURITUS GENERALISED 101 0.0047
333 BLOOD ALBUMIN DECREASED 37 0.0047
334 COORDINATION ABNORMAL 65 0.0047
335 ANGIOEDEMA 206 0.0047
336 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 79 0.0046
337 PRURITUS 1787 0.0046
338 MALNUTRITION 52 0.0046
339 ANXIETY 1320 0.0046
340 BLOOD CHOLESTEROL INCREASED 216 0.0046
341 CELLULITIS 233 0.0046
342 TOOTH ABSCESS 47 0.0046
343 OCULAR HYPERAEMIA 219 0.0046
344 FORMICATION 32 0.0046
345 NO THERAPEUTIC RESPONSE 56 0.0046
346 MENSTRUAL DISORDER 38 0.0046
347 WHITE BLOOD CELL COUNT INCREASED 176 0.0046
348 UNEVALUABLE EVENT 347 0.0046
349 TENDONITIS 71 0.0046
350 POLLAKIURIA 191 0.0046
351 HYPOAESTHESIA ORAL 69 0.0046
352 THERAPEUTIC RESPONSE CHANGED 29 0.0046
353 TYPE 2 DIABETES MELLITUS 154 0.0046
354 RESPIRATORY TRACT INFECTION 119 0.0046
355 HEADACHE 2860 0.0046
356 CYSTITIS 145 0.0045
357 NEUROPATHY PERIPHERAL 433 0.0045
358 CHOLECYSTECTOMY 52 0.0045
359 CHEST PAIN 842 0.0045
360 LOCAL SWELLING 79 0.0045
361 APPETITE DISORDER 30 0.0045
362 ACUTE RESPIRATORY FAILURE 87 0.0045
363 EYE INFECTION 51 0.0045
364 FULL BLOOD COUNT DECREASED 91 0.0045
365 HOT FLUSH 340 0.0045
366 WRIST FRACTURE 54 0.0045
367 CANDIDA INFECTION 76 0.0045
368 INFUSION SITE EXTRAVASATION 28 0.0045
369 DEPRESSION 1022 0.0045
370 HAEMOPTYSIS 125 0.0045
371 IMPAIRED GASTRIC EMPTYING 61 0.0045
372 BLOOD PRESSURE DIASTOLIC DECREASED 33 0.0045
373 LYMPHADENOPATHY 158 0.0045
374 SWELLING OF EYELID 28 0.0045
375 ECZEMA 233 0.0044
376 HYPOTHYROIDISM 142 0.0044
377 BACK PAIN 1031 0.0044
378 ARTHRITIS 349 0.0044
379 MASS 62 0.0044
380 SUNBURN 33 0.0044
381 HEART RATE IRREGULAR 100 0.0044
382 ABDOMINAL DISCOMFORT 742 0.0044
383 URINARY TRACT INFECTION 754 0.0044
384 DYSURIA 162 0.0044
385 GINGIVAL PAIN 35 0.0044
386 NASOPHARYNGITIS 807 0.0044
387 INFUSION RELATED REACTION 290 0.0044
388 BODY TEMPERATURE DECREASED 43 0.0044
389 UPPER LIMB FRACTURE 87 0.0044
390 DIZZINESS 2173 0.0044
391 DECREASED ACTIVITY 47 0.0044
392 RESPIRATION ABNORMAL 30 0.0043
393 RASH MACULAR 152 0.0043
394 GOUT 78 0.0043
395 FEELING COLD 121 0.0043
396 FLATULENCE 246 0.0043
397 PANIC ATTACK 158 0.0043
398 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 226 0.0043
399 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 146 0.0043
400 SKIN LACERATION 47 0.0043
401 MUSCLE DISORDER 35 0.0043
402 RETCHING 92 0.0043
403 BOWEL MOVEMENT IRREGULARITY 33 0.0043
404 TENDON DISORDER 28 0.0043
405 INJURY 301 0.0043
406 RESPIRATORY RATE INCREASED 38 0.0043
407 DISCOMFORT 261 0.0043
408 PRODUCT LABEL ISSUE 29 0.0043
409 HYSTERECTOMY 37 0.0043
410 BLOOD TEST ABNORMAL 60 0.0043
411 SPLENOMEGALY 50 0.0043
412 CARDIOMYOPATHY 63 0.0043
413 FATIGUE 3318 0.0043
414 PAPULE 30 0.0043
415 ANGER 144 0.0043
416 ACTIVITIES OF DAILY LIVING IMPAIRED 84 0.0042
417 INJECTION SITE URTICARIA 104 0.0042
418 LIMB INJURY 115 0.0042
419 ORAL DISORDER 31 0.0042
420 CLOSTRIDIUM DIFFICILE INFECTION 92 0.0042
421 TRANSIENT ISCHAEMIC ATTACK 142 0.0042
422 CONTUSION 405 0.0042
423 JOINT EFFUSION 29 0.0042
424 BLOOD TRIGLYCERIDES INCREASED 74 0.0042
425 CONSTIPATION 913 0.0042
426 TOOTH DISORDER 93 0.0042
427 DRUG SCREEN POSITIVE 33 0.0042
428 MUSCLE SPASMS 765 0.0042
429 FOOT FRACTURE 79 0.0042
430 CHROMATURIA 94 0.0042
431 BRONCHIECTASIS 28 0.0042
432 DISTURBANCE IN ATTENTION 224 0.0041
433 CHOKING 81 0.0041
434 VISUAL FIELD DEFECT 30 0.0041
435 ADVERSE REACTION 55 0.0041
436 PLATELET COUNT INCREASED 54 0.0041
437 HEPATIC STEATOSIS 77 0.0041
438 PARAESTHESIA 650 0.0041
439 CHILLS 484 0.0041
440 ABDOMINAL PAIN UPPER 850 0.0041
441 SCAB 47 0.0041
442 DYSPHAGIA 391 0.0041
443 VERTIGO 251 0.0041
444 ANAL INCONTINENCE 37 0.0041
445 GASTROENTERITIS 60 0.0041
446 MOOD ALTERED 112 0.0041
447 DYSPNOEA 2323 0.0041
448 OCULAR DISCOMFORT 46 0.0041
449 CROHN'S DISEASE 28 0.0041
450 URINARY INCONTINENCE 121 0.0041
451 CATARACT 243 0.0041
452 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 290 0.0041
453 ANHEDONIA 107 0.0041
454 BODY TEMPERATURE INCREASED 83 0.0041
455 ATRIAL SEPTAL DEFECT 34 0.0041
456 EYE PAIN 229 0.0041
457 POST PROCEDURAL INFECTION 33 0.0041
458 EMOTIONAL DISORDER 125 0.0041
459 GLAUCOMA 78 0.0040
460 SKIN FISSURES 79 0.0040
461 OSTEOMYELITIS 73 0.0040
462 OEDEMA PERIPHERAL 491 0.0040
463 IMMUNE SYSTEM DISORDER 53 0.0040
464 RASH 1753 0.0040
465 LYMPHOCYTE COUNT DECREASED 71 0.0040
466 CORONARY ARTERY OCCLUSION 55 0.0040
467 PERIPHERAL COLDNESS 55 0.0040
468 NIGHT SWEATS 129 0.0040
469 RIB FRACTURE 82 0.0040
470 INFLUENZA 444 0.0040
471 PAROSMIA 30 0.0040
472 MUSCULOSKELETAL PAIN 208 0.0040
473 OXYGEN SATURATION DECREASED 223 0.0040
474 PELVIC PAIN 72 0.0040
475 BLOOD COUNT ABNORMAL 60 0.0040
476 SLEEP DISORDER 279 0.0039
477 FLANK PAIN 37 0.0039
478 LIMB DISCOMFORT 122 0.0039
479 ERYTHEMA 810 0.0039
480 BREAST PAIN 42 0.0039
481 BACK DISORDER 64 0.0039
482 LETHARGY 226 0.0039
483 DRUG EFFECT LESS THAN EXPECTED 58 0.0039
484 NODULE 51 0.0039
485 PAIN IN EXTREMITY 1147 0.0039
486 NAIL DISORDER 34 0.0039
487 GLOSSODYNIA 87 0.0039
488 HUNGER 54 0.0039
489 MOOD SWINGS 123 0.0039
490 SKIN DISCOLOURATION 177 0.0038
491 AGEUSIA 96 0.0038
492 HOSPICE CARE 38 0.0038
493 OESOPHAGITIS 42 0.0038
494 NAUSEA 3042 0.0038
495 FUNGAL INFECTION 128 0.0038
496 ELECTROCARDIOGRAM ABNORMAL 30 0.0038
497 BLOOD SODIUM DECREASED 72 0.0038
498 MOUTH HAEMORRHAGE 28 0.0038
499 BURNING SENSATION 267 0.0038
500 IMPAIRED HEALING 125 0.0038
501 EYE IRRITATION 219 0.0038
502 PERIPHERAL SWELLING 586 0.0038
503 HYPOAESTHESIA 569 0.0038
504 MYALGIA 646 0.0038
505 AUTOIMMUNE DISORDER 37 0.0038
506 URINE OUTPUT DECREASED 33 0.0038
507 HYPERAESTHESIA 31 0.0038
508 BACK INJURY 41 0.0038
509 SCIATICA 60 0.0038
510 HEAD INJURY 119 0.0038
511 ATRIAL FIBRILLATION 366 0.0038
512 DEHYDRATION 500 0.0037
513 WEIGHT DECREASED 1046 0.0037
514 PULMONARY EMBOLISM 356 0.0037
515 RENAL INJURY 111 0.0037
516 HYPERTENSION 790 0.0037
517 HEREDITARY ANGIOEDEMA 40 0.0037
518 DERMATITIS 78 0.0037
519 HYPOXIA 131 0.0037
520 EOSINOPHIL COUNT INCREASED 31 0.0037
521 TOOTH FRACTURE 41 0.0037
522 PRODUCT PHYSICAL ISSUE 75 0.0037
523 DIZZINESS POSTURAL 36 0.0037
524 VISION BLURRED 508 0.0037
525 DIARRHOEA 2382 0.0037
526 AFFECTIVE DISORDER 29 0.0037
527 RENAL PAIN 39 0.0037
528 PERICARDIAL EFFUSION 85 0.0037
529 EYE HAEMORRHAGE 49 0.0037
530 OVERDOSE 792 0.0037
531 ILLNESS 378 0.0037
532 EATING DISORDER 78 0.0037
533 PRESYNCOPE 89 0.0037
534 ABNORMAL BEHAVIOUR 145 0.0037
535 ABNORMAL DREAMS 101 0.0037
536 BALANCE DISORDER 316 0.0037
537 PNEUMONIA 1183 0.0037
538 BLOOD CALCIUM DECREASED 41 0.0036
539 THERAPEUTIC RESPONSE DECREASED 221 0.0036
540 IRRITABILITY 219 0.0036
541 DEVICE RELATED INFECTION 56 0.0036
542 STAPHYLOCOCCAL INFECTION 120 0.0036
543 ATRIAL FLUTTER 29 0.0036
544 THYROID DISORDER 56 0.0036
545 DERMATITIS ATOPIC 191 0.0036
546 WEIGHT INCREASED 811 0.0036
547 HERPES ZOSTER 208 0.0036
548 NEPHROLITHIASIS 166 0.0036
549 KIDNEY INFECTION 71 0.0036
550 INCREASED APPETITE 69 0.0036
551 DRY SKIN 482 0.0036
552 SENSORY LOSS 29 0.0036
553 SWELLING 337 0.0036
554 FLUID RETENTION 183 0.0036
555 NERVE INJURY 40 0.0036
556 PARANOIA 62 0.0036
557 BACTERIAL INFECTION 67 0.0036
558 ABDOMINAL DISTENSION 374 0.0036
559 INFLAMMATORY BOWEL DISEASE 35 0.0036
560 CARDIAC FAILURE CONGESTIVE 287 0.0036
561 SKIN LESION 98 0.0036
562 MENTAL STATUS CHANGES 99 0.0036
563 INCORRECT DOSE ADMINISTERED 813 0.0036
564 RESPIRATORY SYNCYTIAL VIRUS INFECTION 31 0.0036
565 EYE DISORDER 117 0.0036
566 HYPERHIDROSIS 458 0.0036
567 TASTE DISORDER 72 0.0035
568 INFLUENZA LIKE ILLNESS 292 0.0035
569 BLOOD PRESSURE FLUCTUATION 85 0.0035
570 LUNG INFECTION 55 0.0035
571 WHITE BLOOD CELL COUNT DECREASED 383 0.0035
572 OSTEOPOROSIS 145 0.0035
573 LIP DRY 32 0.0035
574 ARTERIOSCLEROSIS 33 0.0035
575 PLEURAL EFFUSION 213 0.0035
576 ARTHRALGIA 1452 0.0035
577 ANGINA PECTORIS 100 0.0035
578 DEVICE FAILURE 53 0.0035
579 BLOOD PRESSURE ABNORMAL 69 0.0035
580 COELIAC DISEASE 34 0.0035
581 HERNIA 67 0.0035
582 ADRENAL INSUFFICIENCY 42 0.0035
583 COLD SWEAT 61 0.0035
584 PRODUCT ODOUR ABNORMAL 36 0.0034
585 COVID-19 601 0.0034
586 PLATELET COUNT DECREASED 365 0.0034
587 ASTHENIA 1284 0.0034
588 STOMATITIS 207 0.0034
589 RASH ERYTHEMATOUS 163 0.0034
590 INCONTINENCE 36 0.0034
591 BASAL CELL CARCINOMA 53 0.0034
592 RENAL FAILURE 451 0.0034
593 CLOSTRIDIUM DIFFICILE COLITIS 36 0.0034
594 PAIN 2082 0.0034
595 MUSCLE TWITCHING 78 0.0034
596 SINUS TACHYCARDIA 48 0.0034
597 OEDEMA 183 0.0034
598 GINGIVAL BLEEDING 46 0.0034
599 DEPRESSED MOOD 178 0.0034
600 RENAL TUBULAR NECROSIS 33 0.0034
601 BRONCHOSPASM 48 0.0034
602 ABDOMINAL PAIN 781 0.0034
603 DRUG ADMINISTRATION ERROR 102 0.0033
604 HYPOKALAEMIA 153 0.0033
605 JOINT DISLOCATION 35 0.0033
606 FEAR 89 0.0033
607 BLOOD PRESSURE DECREASED 219 0.0033
608 GASTRIC DISORDER 113 0.0033
609 MENTAL DISORDER 143 0.0033
610 RASH GENERALISED 85 0.0033
611 DRUG PRESCRIBING ERROR 63 0.0033
612 JOINT STIFFNESS 86 0.0033
613 JOINT INJURY 70 0.0033
614 MACULAR DEGENERATION 39 0.0033
615 BLOOD THYROID STIMULATING HORMONE INCREASED 30 0.0033
616 ABSCESS 52 0.0033
617 FOOT DEFORMITY 36 0.0032
618 BRAIN OEDEMA 41 0.0032
619 SEDATION 85 0.0032
620 TENDON RUPTURE 40 0.0032
621 FALL 1078 0.0032
622 HAEMOGLOBIN DECREASED 332 0.0032
623 PERSONALITY CHANGE 30 0.0032
624 TREMOR 536 0.0032
625 MUSCULAR WEAKNESS 367 0.0032
626 POST PROCEDURAL COMPLICATION 62 0.0032
627 DEFORMITY 30 0.0032
628 INJECTION SITE WARMTH 66 0.0032
629 HYPOPHAGIA 82 0.0032
630 LEUKOCYTOSIS 58 0.0032
631 RENAL DISORDER 149 0.0032
632 FAECES DISCOLOURED 69 0.0032
633 ANOREXIA 41 0.0032
634 GRIP STRENGTH DECREASED 28 0.0032
635 PULMONARY ARTERIAL HYPERTENSION 46 0.0032
636 SKIN HAEMORRHAGE 47 0.0032
637 COGNITIVE DISORDER 148 0.0032
638 ROAD TRAFFIC ACCIDENT 132 0.0032
639 ERUCTATION 61 0.0031
640 THERAPY CHANGE 31 0.0031
641 DYSSTASIA 92 0.0031
642 URINARY RETENTION 105 0.0031
643 APHASIA 95 0.0031
644 RESPIRATORY DISORDER 94 0.0031
645 PYREXIA 1086 0.0031
646 DECREASED APPETITE 727 0.0031
647 INJECTION SITE RASH 96 0.0031
648 BONE DISORDER 57 0.0031
649 SUICIDAL IDEATION 286 0.0031
650 VOMITING 1458 0.0031
651 MUSCULOSKELETAL DISORDER 59 0.0031
652 PNEUMOTHORAX 49 0.0031
653 SMALL INTESTINAL OBSTRUCTION 38 0.0031
654 DIPLOPIA 80 0.0031
655 ALOPECIA 604 0.0031
656 INJECTION SITE PRURITUS 206 0.0031
657 AMNESIA 200 0.0031
658 PETECHIAE 32 0.0031
659 VAGINAL HAEMORRHAGE 133 0.0031
660 VAGINAL DISCHARGE 31 0.0031
661 THINKING ABNORMAL 57 0.0031
662 GASTRIC ULCER 58 0.0030
663 SYNCOPE 305 0.0030
664 SKIN EXFOLIATION 257 0.0030
665 SLUGGISHNESS 31 0.0030
666 NIGHTMARE 105 0.0030
667 GAIT DISTURBANCE 580 0.0030
668 SKIN DISORDER 101 0.0030
669 FACE OEDEMA 51 0.0030
670 ORAL HERPES 59 0.0030
671 LOWER LIMB FRACTURE 58 0.0030
672 BLOOD POTASSIUM INCREASED 49 0.0030
673 DYSMENORRHOEA 40 0.0030
674 SPEECH DISORDER 157 0.0030
675 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 540 0.0030
676 KNEE ARTHROPLASTY 63 0.0030
677 BLISTER 168 0.0030
678 METRORRHAGIA 51 0.0030
679 THROMBOSIS 240 0.0030
680 JOINT SWELLING 359 0.0030
681 UPPER GASTROINTESTINAL HAEMORRHAGE 50 0.0030
682 PAIN OF SKIN 80 0.0030
683 MEMORY IMPAIRMENT 407 0.0030
684 FEEDING DISORDER 60 0.0030
685 EYELID PTOSIS 30 0.0029
686 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 210 0.0029
687 IMMUNODEFICIENCY 44 0.0029
688 PRESCRIBED OVERDOSE 57 0.0029
689 PULMONARY THROMBOSIS 32 0.0029
690 FULL BLOOD COUNT ABNORMAL 31 0.0029
691 EUPHORIC MOOD 30 0.0029
692 SKIN IRRITATION 134 0.0029
693 PROCEDURAL PAIN 81 0.0029
694 MALAISE 1280 0.0029
695 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 591 0.0029
696 AFFECT LABILITY 28 0.0029
697 GASTROINTESTINAL PAIN 32 0.0029
698 IMPAIRED WORK ABILITY 62 0.0029
699 PRODUCT AVAILABILITY ISSUE 66 0.0029
700 AGGRESSION 145 0.0029
701 MOUTH ULCERATION 61 0.0029
702 HEMIPARESIS 49 0.0029
703 MUSCULOSKELETAL STIFFNESS 252 0.0029
704 TRANSFUSION 30 0.0029
705 ACNE 217 0.0029
706 DISORIENTATION 113 0.0028
707 HEPATOMEGALY 28 0.0028
708 INFLAMMATION 147 0.0028
709 HEART RATE DECREASED 100 0.0028
710 SPINAL FRACTURE 57 0.0028
711 SEPSIS 317 0.0028
712 RESTLESSNESS 104 0.0028
713 LIVER FUNCTION TEST INCREASED 61 0.0028
714 WRONG TECHNIQUE IN DRUG USAGE PROCESS 103 0.0028
715 POST PROCEDURAL HAEMORRHAGE 33 0.0028
716 SURGERY 166 0.0028
717 WOUND INFECTION 31 0.0028
718 SKIN ULCER 73 0.0028
719 ALANINE AMINOTRANSFERASE INCREASED 173 0.0028
720 LOSS OF CONSCIOUSNESS 361 0.0028
721 FLUID OVERLOAD 41 0.0028
722 ANAEMIA 537 0.0028
723 BEDRIDDEN 37 0.0028
724 LOCALISED INFECTION 68 0.0028
725 HIP ARTHROPLASTY 43 0.0028
726 HEPATIC ENZYME INCREASED 191 0.0028
727 SARS-COV-2 TEST POSITIVE 37 0.0028
728 MENORRHAGIA 55 0.0028
729 PRODUCT DOSE OMISSION IN ERROR 79 0.0028
730 LIVER FUNCTION TEST ABNORMAL 81 0.0028
731 CONVULSION 159 0.0028
732 LABORATORY TEST ABNORMAL 82 0.0028
733 BLOOD LACTATE DEHYDROGENASE INCREASED 44 0.0028
734 FREQUENT BOWEL MOVEMENTS 75 0.0028
735 ABDOMINAL PAIN LOWER 70 0.0028
736 DIABETES MELLITUS 211 0.0028
737 GLOMERULAR FILTRATION RATE DECREASED 34 0.0028
738 DYSARTHRIA 104 0.0028
739 PRODUCT DOSE OMISSION 180 0.0028
740 INJECTION SITE DISCOMFORT 29 0.0028
741 RENAL FAILURE ACUTE 117 0.0028
742 UNDERDOSE 201 0.0028
743 EYELID OEDEMA 32 0.0028
744 CAESAREAN SECTION 32 0.0027
745 GENERALISED OEDEMA 34 0.0027
746 FEMUR FRACTURE 85 0.0027
747 SKIN BURNING SENSATION 196 0.0027
748 TOOTH EXTRACTION 34 0.0027
749 ASPARTATE AMINOTRANSFERASE INCREASED 145 0.0027
750 CONDITION AGGRAVATED 829 0.0027
751 RECTAL HAEMORRHAGE 117 0.0027
752 BLOOD GLUCOSE DECREASED 130 0.0027
753 TACHYCARDIA 240 0.0027
754 DRUG DOSE OMISSION 445 0.0027
755 COMPLICATION ASSOCIATED WITH DEVICE 39 0.0027
756 HYPOTENSION 538 0.0027
757 HALLUCINATION 202 0.0027
758 GASTROINTESTINAL DISORDER 240 0.0027
759 PHARMACEUTICAL PRODUCT COMPLAINT 69 0.0027
760 INTESTINAL OBSTRUCTION 100 0.0027
761 THERAPY CESSATION 136 0.0026
762 ACUTE MYOCARDIAL INFARCTION 78 0.0026
763 PRODUCT PRESCRIBING ERROR 63 0.0026
764 COAGULOPATHY 44 0.0026
765 INJECTION SITE SWELLING 202 0.0026
766 PRODUCT DOSE OMISSION ISSUE 775 0.0026
767 ADVERSE DRUG REACTION 236 0.0026
768 NEUTROPHIL COUNT DECREASED 107 0.0026
769 INJECTION SITE ERYTHEMA 325 0.0026
770 PALLOR 71 0.0026
771 DYSKINESIA 106 0.0026
772 PRODUCT QUALITY ISSUE 354 0.0026
773 HAEMATEMESIS 66 0.0026
774 THERAPY NON-RESPONDER 117 0.0026
775 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 125 0.0026
776 BLOOD CREATININE INCREASED 169 0.0026
777 OFF LABEL USE 2261 0.0026
778 INJECTION SITE BRUISING 205 0.0026
779 INTENTIONAL DOSE OMISSION 73 0.0026
780 SPINAL PAIN 30 0.0026
781 AGITATION 188 0.0026
782 ASPIRATION 28 0.0026
783 PRODUCT SUBSTITUTION ISSUE 147 0.0026
784 LUNG DISORDER 125 0.0025
785 VISUAL IMPAIRMENT 316 0.0025
786 MOBILITY DECREASED 183 0.0025
787 DERMATITIS ALLERGIC 32 0.0025
788 HAEMATOCHEZIA 140 0.0025
789 PNEUMONITIS 69 0.0025
790 BACTERAEMIA 30 0.0025
791 MUSCLE ATROPHY 32 0.0025
792 COMA 120 0.0025
793 BLOOD BILIRUBIN INCREASED 68 0.0025
794 PARALYSIS 36 0.0025
795 PSORIATIC ARTHROPATHY 102 0.0025
796 EJECTION FRACTION DECREASED 39 0.0025
797 HYPERGLYCAEMIA 91 0.0025
798 DIABETES MELLITUS INADEQUATE CONTROL 44 0.0025
799 PSORIASIS 324 0.0025
800 CONFUSIONAL STATE 399 0.0025
801 INFECTION 357 0.0025
802 IMPAIRED DRIVING ABILITY 28 0.0025
803 EMOTIONAL DISTRESS 298 0.0025
804 JOINT RANGE OF MOTION DECREASED 33 0.0025
805 GLYCOSYLATED HAEMOGLOBIN INCREASED 62 0.0025
806 TUBULOINTERSTITIAL NEPHRITIS 46 0.0025
807 GAIT INABILITY 82 0.0025
808 ATAXIA 29 0.0024
809 SPINAL OPERATION 30 0.0024
810 MOVEMENT DISORDER 78 0.0024
811 COLITIS 92 0.0024
812 CARDIAC DISORDER 227 0.0024
813 INTRAOCULAR PRESSURE INCREASED 31 0.0024
814 HAEMATURIA 83 0.0024
815 VENTRICULAR TACHYCARDIA 40 0.0024
816 INCORRECT DRUG ADMINISTRATION DURATION 68 0.0024
817 INCORRECT PRODUCT ADMINISTRATION DURATION 52 0.0024
818 PANCREATITIS 126 0.0024
819 DEAFNESS 62 0.0024
820 C-REACTIVE PROTEIN INCREASED 86 0.0024
821 CYANOSIS 37 0.0024
822 DEVICE OCCLUSION 33 0.0023
823 PULMONARY OEDEMA 105 0.0023
824 ARRHYTHMIA 111 0.0023
825 INTENTIONAL PRODUCT USE ISSUE 205 0.0023
826 PLASMA CELL MYELOMA 91 0.0023
827 DISABILITY 46 0.0023
828 SKIN CANCER 50 0.0023
829 METASTASES TO BONE 38 0.0023
830 INJECTION SITE PAIN 710 0.0023
831 INJECTION SITE INDURATION 30 0.0023
832 DRUG ERUPTION 41 0.0023
833 ACUTE KIDNEY INJURY 352 0.0023
834 HYPOMAGNESAEMIA 32 0.0023
835 GASTROINTESTINAL HAEMORRHAGE 192 0.0023
836 DISEASE RECURRENCE 109 0.0023
837 RESPIRATORY DISTRESS 63 0.0023
838 MUSCLE SPASTICITY 28 0.0023
839 HYPERCALCAEMIA 28 0.0023
840 ABASIA 56 0.0023
841 RHEUMATOID ARTHRITIS 257 0.0023
842 VISUAL ACUITY REDUCED 75 0.0023
843 DEVICE DISLOCATION 98 0.0023
844 ARTHROPATHY 125 0.0022
845 SENSORY DISTURBANCE 36 0.0022
846 SEIZURE 259 0.0022
847 INJECTION SITE REACTION 154 0.0022
848 OSTEONECROSIS OF JAW 55 0.0022
849 INTENTIONAL PRODUCT MISUSE 194 0.0022
850 RESPIRATORY FAILURE 161 0.0022
851 THERAPEUTIC PRODUCT EFFECT DECREASED 98 0.0022
852 CENTRAL NERVOUS SYSTEM LESION 30 0.0022
853 HIP FRACTURE 70 0.0022
854 PULMONARY FIBROSIS 41 0.0021
855 HALLUCINATION, VISUAL 45 0.0021
856 UNRESPONSIVE TO STIMULI 55 0.0021
857 MENSTRUATION IRREGULAR 57 0.0021
858 APATHY 31 0.0021
859 DELUSION 33 0.0021
860 HAEMORRHAGE 222 0.0021
861 MULTIPLE SCLEROSIS 101 0.0021
862 MYOCARDIAL INFARCTION 367 0.0021
863 APPLICATION SITE ERYTHEMA 55 0.0021
864 HYPOACUSIS 90 0.0021
865 APPLICATION SITE PAIN 46 0.0021
866 WITHDRAWAL SYNDROME 87 0.0021
867 LYMPHOMA 32 0.0021
868 ORTHOSTATIC HYPOTENSION 36 0.0021
869 MANIA 34 0.0021
870 BLINDNESS UNILATERAL 29 0.0021
871 LIVER DISORDER 91 0.0020
872 HAEMATOMA 53 0.0020
873 BLINDNESS 83 0.0020
874 ENCEPHALOPATHY 50 0.0020
875 FEBRILE NEUTROPENIA 135 0.0020
876 CEREBROVASCULAR ACCIDENT 344 0.0020
877 SUBDURAL HAEMATOMA 29 0.0020
878 LOWER RESPIRATORY TRACT INFECTION 92 0.0020
879 DRUG INTOLERANCE 195 0.0020
880 DISEASE PROGRESSION 236 0.0020
881 ERECTILE DYSFUNCTION 51 0.0020
882 PRODUCT ADMINISTRATION ERROR 40 0.0020
883 BONE DENSITY DECREASED 62 0.0020
884 MULTIPLE SCLEROSIS RELAPSE 135 0.0020
885 NERVOUS SYSTEM DISORDER 61 0.0020
886 BREAST CANCER FEMALE 52 0.0019
887 WOUND 54 0.0019
888 ADVERSE EVENT 177 0.0019
889 INJECTION SITE MASS 71 0.0019
890 PREGNANCY 38 0.0019
891 HYPOGLYCAEMIA 92 0.0019
892 DEMENTIA 53 0.0019
893 PSYCHOTIC DISORDER 56 0.0019
894 INTERNATIONAL NORMALISED RATIO INCREASED 54 0.0019
895 BLOOD GLUCOSE INCREASED 354 0.0019
896 ASCITES 55 0.0019
897 EXPOSURE VIA SKIN CONTACT 48 0.0019
898 APPLICATION SITE PRURITUS 42 0.0018
899 DEVICE MALFUNCTION 129 0.0018
900 TOOTH LOSS 38 0.0018
901 NO ADVERSE EVENT 328 0.0018
902 GAMMA-GLUTAMYLTRANSFERASE INCREASED 40 0.0018
903 EXPOSURE DURING PREGNANCY 112 0.0018
904 ACUTE MYELOID LEUKAEMIA 28 0.0018
905 PANCYTOPENIA 100 0.0018
906 THERAPY INTERRUPTED 127 0.0018
907 COLITIS ULCERATIVE 79 0.0018
908 METASTASES TO LIVER 31 0.0018
909 HALLUCINATION, AUDITORY 28 0.0018
910 DEVICE ISSUE 157 0.0017
911 ANAPHYLACTIC SHOCK 45 0.0017
912 SHOCK 40 0.0017
913 MENTAL IMPAIRMENT 42 0.0017
914 CEREBRAL INFARCTION 42 0.0017
915 MUCOSAL INFLAMMATION 45 0.0017
916 INJECTION SITE HAEMORRHAGE 137 0.0017
917 DRUG EXPOSURE DURING PREGNANCY 58 0.0017
918 SUICIDE ATTEMPT 103 0.0017
919 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 39 0.0017
920 DIABETIC KETOACIDOSIS 40 0.0017
921 PRESCRIBED UNDERDOSE 33 0.0017
922 HYPERKALAEMIA 58 0.0017
923 HEPATIC CIRRHOSIS 31 0.0016
924 SYSTEMIC LUPUS ERYTHEMATOSUS 58 0.0016
925 ILL-DEFINED DISORDER 98 0.0016
926 MEDICATION ERROR 89 0.0016
927 HYPONATRAEMIA 89 0.0016
928 TREATMENT NONCOMPLIANCE 85 0.0016
929 ACCIDENTAL EXPOSURE TO PRODUCT 159 0.0015
930 BLOOD CREATINE PHOSPHOKINASE INCREASED 44 0.0015
931 TARDIVE DYSKINESIA 43 0.0015
932 PANCREATITIS ACUTE 34 0.0015
933 GENERAL PHYSICAL HEALTH DETERIORATION 175 0.0015
934 MELAENA 33 0.0015
935 DEVICE DELIVERY SYSTEM ISSUE 41 0.0015
936 JAUNDICE 40 0.0015
937 RASH MACULO-PAPULAR 33 0.0015
938 NEEDLE ISSUE 43 0.0015
939 RENAL IMPAIRMENT 124 0.0015
940 HOSPITALISATION 224 0.0015
941 CONTRAINDICATED PRODUCT ADMINISTERED 44 0.0015
942 MATERNAL EXPOSURE DURING PREGNANCY 129 0.0014
943 STEVENS-JOHNSON SYNDROME 32 0.0014
944 NEOPLASM PROGRESSION 50 0.0014
945 SEPTIC SHOCK 62 0.0014
946 THROMBOCYTOPENIA 159 0.0014
947 BRADYCARDIA 74 0.0014
948 CARDIAC FAILURE 111 0.0014
949 CARDIOVASCULAR DISORDER 35 0.0014
950 ABORTION SPONTANEOUS 55 0.0014
951 OSTEONECROSIS 45 0.0014
952 DRUG INTERACTION 217 0.0014
953 PRODUCT PREPARATION ERROR 28 0.0014
954 ELECTROCARDIOGRAM QT PROLONGED 49 0.0014
955 PRODUCT DISPENSING ERROR 29 0.0013
956 NEUTROPENIA 178 0.0013
957 ALTERED STATE OF CONSCIOUSNESS 28 0.0013
958 HEPATITIS 33 0.0013
959 EXTRAPYRAMIDAL DISORDER 32 0.0013
960 NEOPLASM MALIGNANT 86 0.0013
961 CEREBRAL HAEMORRHAGE 46 0.0013
962 DEVICE BREAKAGE 52 0.0013
963 INTERSTITIAL LUNG DISEASE 62 0.0013
964 DELIRIUM 43 0.0012
965 HEPATIC FUNCTION ABNORMAL 46 0.0012
966 DEPRESSED LEVEL OF CONSCIOUSNESS 47 0.0012
967 PRODUCT ADHESION ISSUE 42 0.0012
968 BREAST CANCER 108 0.0012
969 EPILEPSY 35 0.0011
970 HEPATIC FAILURE 34 0.0011
971 CARDIAC ARREST 93 0.0011
972 DRUG WITHDRAWAL SYNDROME 98 0.0011
973 MALIGNANT NEOPLASM PROGRESSION 114 0.0011
974 DEVICE LEAKAGE 48 0.0011
975 CARDIO-RESPIRATORY ARREST 46 0.0011
976 LEUKOPENIA 55 0.0011
977 DEVICE USE ERROR 36 0.0010
978 LUNG NEOPLASM MALIGNANT 39 0.0009
979 METABOLIC ACIDOSIS 30 0.0009
980 DEATH 740 0.0009
981 DRUG DOSE OMISSION BY DEVICE 67 0.0009
982 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 38 0.0008
983 RHABDOMYOLYSIS 32 0.0008
984 DEVICE EXPULSION 49 0.0008
985 TREATMENT FAILURE 52 0.0006
986 PRODUCT STORAGE ERROR 47 0.0005
987 INTENTIONAL OVERDOSE 33 0.0005
988 DEVICE DIFFICULT TO USE 32 0.0005
989 PROSTATE CANCER 38 0.0005
990 FOETAL EXPOSURE DURING PREGNANCY 37 0.0005
991 DRUG DEPENDENCE 64 0.0004
992 COMPLETED SUICIDE 30 0.0004
993 TOXICITY TO VARIOUS AGENTS 56 0.0003